For research use only
| Cat No. | ABC-TC151W |
| Product Type | Gastric Cancer Tumor Cells |
| Cell Type | Tumor Cell |
| Species | Human |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Gastric carcinoma tissues |
| Disease | Gastric Cancer |
| Storage | Liquid Nitrogen |
Human Gastric Cancer Tumor Cells support research on gastric tumor biology, metastasis, drug testing, and targeted therapy development in vitro.
Human Gastric Cancer Tumor Cells are derived from human gastric carcinoma tissues, serving as critical models for studying gastric tumorigenesis, progression, and treatment response. These cells retain hallmark features such as uncontrolled proliferation, metastatic potential, and resistance to apoptosis, reflecting the complex clinical pathology of gastric cancer. Widely utilized to investigate molecular pathways including HER2 signaling, epithelial-mesenchymal transition (EMT), and tumor-microenvironment interactions, these cells facilitate the discovery of novel therapeutic targets and biomarkers. They are instrumental in drug screening, resistance studies, and personalized therapeutic strategy development.
| Species | Human |
| Cat.No | ABC-TC151W |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Tumor Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Gastric carcinoma tissues |
| Disease | Gastric Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Gastric Cancer Tumor Cells |
For research use only.
Human Gastric Cancer Tumor Cells are extensively used for oncology research, enabling the study of cell proliferation, metastasis, and invasion mechanisms. These cells serve as valuable tools for drug screening, biomarker discovery, and understanding chemotherapy resistance. Additionally, they provide a reliable platform for investigating tumor biology, molecular signaling pathways, and developing targeted therapies and personalized medicine approaches.